AIDS InfoNet Logo
This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

The Henry J. Kaiser Family Foundation
Site of the Week
November 2003

The Health Leader Award 2006
The Health Leader Award 2006

The HOPE Reward Medical Award Featured Site Award

IBS Tales Hope Award Editor's Choice Award

Listed in Listed in Treasures of the Internet

AIDS InfoNet Logo.  The AIDS InfoNet - Reliable, Up-to-Date AIDS Treatment Information
International Association of Providers of AIDS Care
Reviewed June 7, 2016

Fact Sheet 518

Tuberculosis (TB)



Tuberculosis (TB) is an infection caused by bacteria. TB usually affects the lungs, but sometimes can affect other organs, especially for people with HIV and a CD4 cell count under 200.

TB is a very serious disease worldwide. Almost one-third of the world's population, and one third of people with HIV are infected with TB. A healthy immune system can usually prevent active disease. TB is a major cause of death for people with HIV worldwide, according to the World Health Organization.

The name tuberculosis comes from tubercles. These are small, hard lumps that form when the immune system builds a wall around the TB bacteria in the lungs. TB in the lungs is called pulmonary TB. The infection can spread from the lungs to the kidneys, spine and brain. This is called extrapulmonary TB. It only shows up in people who have already been infected with TB but who have not been treated. People with HIV who live in areas where TB is common might develop extrapulmonary TB.

Active TB in the lungs can cause coughing for more than 3 weeks, weight loss, constant fatigue, night sweats, and fevers, especially in the evening. These are like the symptoms caused by Pneumocystis pneumonia (PCP, see fact sheet 515). The symptoms can vary if TB is in other parts of the body. If people with HIV and TB have unexplained symptoms, they should rule out active TB disease.

TB is transmitted through the air, when someone with active TB of the lung coughs, sneezes, or talks. The ultraviolet rays in sunlight can kill TB. Good ventilation reduces the risk of TB infection. However, people who live in close contact with people who have active TB become infected easily. This is especially true if you have advanced HIV disease. You can become infected with TB at any CD4 level.



Many viruses and bacteria live in our bodies. A healthy immune system will control these germs so they won't make us sick. If HIV weakens our immune system, they can cause opportunistic infections.

The rate of TB for people with HIV in the United States is 40 times the rate for people who aren't HIV-infected. TB rates all over the world are increasing because of HIV disease.

TB can make HIV multiply faster, lower the CD4 cell count, and make HIV disease worse. This makes it important for people with HIV to prevent and treat TB.



There is a simple skin test for TB infection. A protein found in TB bacteria is injected into the skin of your arm. If your skin reacts with swelling more than a certain size, you have probably been infected with the TB bacteria. People with HIV should get a TB skin test to find out if they were exposed to TB in the past.

If HIV or another disease has damaged your immune system, you might not show any reaction to the skin test, even if you're infected. This condition is called "anergy". If you have anergy, the most common way to test for TB is a sputum culture (see next paragraph.)

A positive skin test usually doesn't mean you have active TB. Your health care provider will check x-rays of your lungs, ask you about other symptoms, examine samples of your sputum (fluid produced in the airways and lungs) and try to grow TB bacteria from those samples. They might also try to grow TB from samples taken from other parts of your body where TB can show up. This can take from two to four weeks depending on what method is used. It is difficult to diagnose active TB, especially in people with HIV, because it can look like pneumonia, other lung problems, or other infections. It can show up outside of the lungs. However, newer, faster tests are being developed.



If you are infected with TB, but don't have the active disease, you should be treated with an antibiotic called isoniazid (INH) for at least 6 months, or with INH plus one or two other drugs for 3 months. INH can cause liver problems, especially for black or Hispanic women. In 2011 a large study showed that using a once a week dose of INH with rifapentine for 3 months was equally effective. The US Centers for Disase Control now recommends this shorter course of treatment. Unfortunately, rifapentine interacts with some protease inhibitors. Dosage adjustments may be required but have not yet been studied.

If you have active TB disease, you will be treated with antibiotics. Because the TB bacteria can develop resistance to individual drugs, you will be given a combination of antibiotics. TB drugs must be taken for at least 6 months. but most cases of TB can be cured with existing antibiotics. If you don't keep taking the medications, the TB in your body might become resistant and the anti-TB drugs will stop working.

There are types of TB that are resistant to some antibiotics. These are called multi-drug resistant TB (MDR-TB) or extensively drug resistant TB (XDR-TB). These types of TB are much harder to treat. More medications have to be taken for a longer period of time. Cure rates are lower than for regular TB. Sirturo (bedaquiline) is the first new TB drug in over 40 years. The FDA approved it at the end of 2012. It works against TB with resistance to current drugs.



Some of the antibiotics used to treat TB can damage your liver or kidneys; so can some antiretroviral medication (ARVs. see fact sheet 403.) It can be difficult to take drugs for both TB and HIV at the same time. INH can cause peripheral neuropathy (see Fact Sheet 555), as can several ARVs, so there can be problems if these drugs are taken together. TB treatment can cause "immune restoration syndrome." (see fact sheet 483.

Also, many ARVs interact with rifampin or rifabutin, which are commonly used to fight TB. They can drop the levels of ARVs in your blood too low to control HIV. ARVs can raise the levels of these TB drugs high enough to cause serious side effects.

Rifampin should not be used with most protease inhibitors or non-nucleoside reverse transcriptase inhibitors. Rifabutin can be used in some cases, but drug doses might have to be changed. There are special guidelines if you take drugs to fight TB and HIV at the same time. They are available on the Internet at Also, people with a CD4 cell count below 100 should take rifabutin at least 3 times a week. This reduces the risk of their TB becoming resistant to rifabutin.



TB is a very serious disease worldwide and kills more people with HIV than any other disease. TB and HIV both make each other worse.

There are effective treatments for TB infection, and for active TB disease. If you are exposed to TB, or have signs of TB, get tested and treated.

The treatments for TB take a long time, and can be difficult to take at the same time as ARVs, but they can cure TB. Some TB drugs interact with ARVs, so treatment has to be carefully planned if you have both HIV and TB.  Be sure you understand how important it is to take TB medications for the complete length of time they are prescribed.



Back to Fact Sheet Categories

International Association of Providers of AIDS Care


The AIDS InfoNet is a project of the International Association of Providers of AIDS Care.


United States National Library of Medicine

Partially funded by the National Library of Medicine

Search Our Site
Newest Fact Sheets
Print This Fact Sheet
You can print this fact sheet on a single page in Microsoft Word (.doc) format or Adobe Acrobat (.pdf) format. Click on the links below to open the document in your browser and then print it.
 Adobe Acrobat PDF
 Microsoft Word

You can print directly from your browser using the link below. The printout will probably go onto a second page.
 Print Version (Web)

Monthly E-mail Updates

The InfoNet updates its Fact Sheets frequently. A listing of each month's changes is posted to several e-mail lists.

If you would like to receive this monthly update by personal e-mail, please click on the SUBMIT button.